Temsirolimus

被引：32

作者：

Rini, Brian

Kar, Santwana

Kirkpatrick, Peter

机构：

[1] Cleveland Clin, Taussig Canc Ctr, Dept Solid Tumor Oncol & Urol, Cleveland, OH 44195 USA

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2007年 / 6卷 / 08期

关键词：

D O I：

10.1038/nrd2382

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Temsirolimus (Torisel; Wyeth) is an inhibitor of the kinase mTOR (mammalian target of rapamycin). It was approved by the US FDA for the treatment of advanced renal cell carcinoma in May 2007.

引用

页码：599 / 600

页数：2

共 14 条

[1] Sunitinib maleate [J].

Atkins, M ;

Jones, CA ;

Kirkpatrick, P .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :279-280

[2] Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J].

Atkins, MB ;

Hidalgo, M ;

Stadler, WM ;

Logan, TF ;

Dutcher, JP ;

Hudes, GR ;

Park, Y ;

Lion, SH ;

Marshall, B ;

Boni, JP ;

Dukart, G ;

Sherman, ML .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :909-918

[3]

BUKOWSKI RM, 2006, J CLIN ONCOL, V24, P4523

[4] Renal-cell carcinoma [J].

Cohen, HT ;

McGovern, FJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2477-2490

[5]

Dutcher JP, 2007, J CLIN ONCOL, V25

[6] Sorafenib in advanced clear-cell renal-cell carcinoma [J].

Escudier, Bernard ;

Eisen, Tim ;

Stadler, Walter M. ;

Szczylik, Cezary ;

Oudard, Stephane ;

Siebels, Michael ;

Negrier, Sylvie ;

Chevreau, Christine ;

Solska, Ewa ;

Desai, Apurva A. ;

Rolland, Frederic ;

Demkow, Tomasz ;

Hutson, Thomas E. ;

Gore, Martin ;

Freeman, Scott ;

Schwartz, Brian ;

Shan, Minghua ;

Simantov, Ronit ;

Bukowski, Ronald M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134

[7]

FALVERE S, 2006, NAT REV DRUG DISCOV, V5, P671

[8]

*FDA, 2007, FDA LAB INF

[9] Recent progress in the management of advanced renal cell carcinoma [J].

Garcia, Jorge A. ;

Rini, Brian I. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (02) :112-125

[10] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].

Motzer, Robert J. ;

Hutson, Thomas E. ;

Tomczak, Piotr ;

Michaelson, M. Dror ;

Bukowski, Ronald M. ;

Rixe, Olivier ;

Oudard, Stephane ;

Negrier, Sylvie ;

Szczylik, Cezary ;

Kim, Sindy T. ;

Chen, Isan ;

Bycott, Paul W. ;

Baum, Charles M. ;

Figlin, Robert A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124

← 1 2 →